{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Innovative%20Formulations%2C%20LLC%20dba%20Insane%20Labz","name":"Innovative Formulations, LLC dba Insane Labz","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-02T22:02:57.458Z"},"count":1,"matches":[{"id":"d01286aea9676526","posted_date":"2024-03-05","letter_issue_date":"2024-02-22","company_name":"Innovative Formulations, LLC dba Insane Labz","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/d01286aea9676526"}]}